X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs TTK HEALTHCARE - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD TTK HEALTHCARE MERCK LTD/
TTK HEALTHCARE
 
P/E (TTM) x 44.7 17.4 256.8% View Chart
P/BV x 5.9 5.9 101.5% View Chart
Dividend Yield % 0.6 0.5 115.1%  

Financials

 MERCK LTD   TTK HEALTHCARE
EQUITY SHARE DATA
    MERCK LTD
Dec-17
TTK HEALTHCARE
Mar-14
MERCK LTD/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,358663 204.6%   
Low Rs933399 233.8%   
Sales per share (Unadj.) Rs665.0535.6 124.2%  
Earnings per share (Unadj.) Rs56.615.9 354.8%  
Cash flow per share (Unadj.) Rs72.520.0 361.9%  
Dividends per share (Unadj.) Rs15.004.00 375.0%  
Dividend yield (eoy) %1.30.8 173.9%  
Book value per share (Unadj.) Rs441.7137.6 321.0%  
Shares outstanding (eoy) m16.607.77 213.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.0 173.6%   
Avg P/E ratio x20.233.3 60.8%  
P/CF ratio (eoy) x15.826.5 59.6%  
Price / Book Value ratio x2.63.9 67.2%  
Dividend payout %26.525.1 105.7%   
Avg Mkt Cap Rs m19,0114,127 460.6%   
No. of employees `0001.51.7 90.4%   
Total wages/salary Rs m1,696607 279.7%   
Avg. sales/employee Rs Th7,150.02,436.7 293.4%   
Avg. wages/employee Rs Th1,098.7355.2 309.4%   
Avg. net profit/employee Rs Th608.272.5 838.5%   
INCOME DATA
Net Sales Rs m11,0404,162 265.3%  
Other income Rs m24061 391.7%   
Total revenues Rs m11,2794,223 267.1%   
Gross profit Rs m1,376197 698.2%  
Depreciation Rs m26432 832.8%   
Interest Rs m030 0.0%   
Profit before tax Rs m1,352197 687.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m58373 800.5%   
Profit after tax Rs m939124 757.9%  
Gross profit margin %12.54.7 263.2%  
Effective tax rate %43.137.0 116.5%   
Net profit margin %8.53.0 285.7%  
BALANCE SHEET DATA
Current assets Rs m7,5231,629 461.9%   
Current liabilities Rs m2,2531,058 213.0%   
Net working cap to sales %47.713.7 348.0%  
Current ratio x3.31.5 216.9%  
Inventory Days Days5230 175.2%  
Debtors Days Days4134 120.7%  
Net fixed assets Rs m1,240556 222.8%   
Share capital Rs m16678 213.6%   
"Free" reserves Rs m7,167878 816.0%   
Net worth Rs m7,3331,069 685.7%   
Long term debt Rs m0159 0.0%   
Total assets Rs m9,9122,399 413.1%  
Interest coverage xNM7.6-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.11.7 64.2%   
Return on assets %9.56.4 147.8%  
Return on equity %12.811.6 110.5%  
Return on capital %20.818.5 112.5%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m1,01533 3,083.9%   
Fx outflow Rs m3,04363 4,815.0%   
Net fx Rs m-2,028-30 6,695.3%   
CASH FLOW
From Operations Rs m537127 423.9%  
From Investments Rs m-476-146 326.2%  
From Financial Activity Rs m-22022 -1,003.7%  
Net Cashflow Rs m-1603 -6,380.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 5.2 19.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.8 112.8%  
Shareholders   28,591 12,723 224.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   AUROBINDO PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  ORCHID PHARMA LTD  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 280 Points Lower; IT and Healthcare Stocks Witness Selling(Closing)

After trading on a negative note throughout the day, share markets in India continued their downtrend during the closing hours and ended the day in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Stop! Read This Before You Cancel Your SIPs(Profit Hunter)

Oct 11, 2018

Read this before you stop your SIP's in equity mutual funds.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

Why Oil Cannot Be Sold to India in Rupees(Vivek Kaul's Diary)

Oct 16, 2018

Oil is bought and sold internationally in terms of dollars. And any change to this, will be attacking the exorbitant privilege of the US dollar.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Oct 23, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - AUROBINDO PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS